Back

A novel SCN5A gene mutation causing LQT3 with unique phenotype in a large canadian kindred

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Ventricular Arrhythmias and Sudden Cardiac Death (SCD) ePosters Long and Short QT Syndromes ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Ciorsti Macintyre

Queen Elizabeth II Health Sciences Center, Halifax (Canada)

34 More presentations in this session

Presentation thumbnail
Usefulness of late gadolinium enhancement cardiac magnetic resonance to predict appropriate therapies in implantable cardioverter defibrillator patients in primary prevention
Miss P. Sanchez Somonte (Girona, ES)
Abstract Slides
Presentation thumbnail
Incidence of sudden cardiac death after heart transplantation
Doctor G. Bonnet (Bordeaux, FR)
Abstract Slides
Presentation thumbnail
Idiopathic HFrEF. Is there room left for defibrillators?
Doctor F. Fernandes Gama (Carnaxide, PT)
Abstract Slides
Presentation thumbnail
Novel plasma biomarkers in arrhythmogenic cardiomyopathy: The role of ST2 and GDF-15 in predicting biventricular involvement
Doctor D. Akdis (Zurich, CH)
Abstract Slides
Presentation thumbnail
Left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy
Doctor N. Parashar (Delhi, IN)
Abstract Slides

Access the full session

Session thumbnail
Ventricular Arrhythmias and Sudden Cardiac Death (SCD) ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Clinical spectrum and phenotypic characteristics of patients with SCN5A variants and cardiomyopathy: early insights from an International Cohort
14 April 2026
thumbnail
Congress Presentation
Accuracy of QTc measurement using a smartwatch mECG in long QT syndrome
1 September 2025
thumbnail
Congress Presentation
Heterogeneity in ECG morphology in LQT3: disparity between genotype & phenotype in a four-generation family
12 April 2026
thumbnail
Congress Presentation
Maturing hiPSC-cardiomyocytes in cardiac microtissues for accurate preclinical in vitro modelling of long-QT syndrome type 1
12 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources